Expanded access requests for AMG 701 may be considered for adult patients with relapsed and/or refractory multiple myeloma whose disease is in partial response or better after AMG 420 therapy. To request access, use Responsible Party contact information provided in this record.
Drug: AMG 701
Inclusion Criteria:
-
Exclusion Criteria:
-
Amgen Call Center
866-572-6436
medinfo@amgen.com
MD
Study Director
Amgen